Evaluating the effectiveness of AI-enhanced “One Body, Two Wings” pharmacovigilance models in China: a nationwide survey on medication safety and risk management
The findings confirm AI's potential to enhance pharmacovigilance, especially in ADR monitoring. However, the study concludes that successful AI integration is predicated on a robust information systems infrastructure, which the data identified as the most critical foundational element. Therefore, optimizing pharmacovigilance in China requires prioritized investment in both this foundational IT and supportive organizational frameworks.
Authors
- Y. Zhang
- Fan Li (ORCID: https://orcid.org/0000-0002-8895-2473)
- Yi Sun
- Jia Wei (ORCID: https://orcid.org/0000-0001-6749-8593)
- Quanzhi Wei
- Jian Yang (ORCID: https://orcid.org/0000-0003-4062-4646)
Institutions
- Kunming Medical University (CN)
- Yunnan Institute For Drug Abuse (CN)
- Yunnan Provincial Department of Education (CN)
- Yuxi Normal University (CN)
- Shijiazhuang Yiling Pharmaceutical (China) (CN)
- Yunnan Environmental Protection Bureau (CN)
Publication Details
- Journal
- Frontiers in Health Services
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/frhs.2025.1655726
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31